– USA, CA – Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy developping transformative therapies for patients with cancer and autoimmune diseases, announced the appointments of James Huang and Nachi Subramanian to its Board of Directors, effective following the completion the $16 million offering that was announced on May 15, 2025.
About James Huang
James Huang has over 37 years of biotech experience and is the Founder and Managing Partner of Panacea Venture. Before Panacea Venture, he was a Managing Partner at Kleiner Perkins China, where he focused on the firm’s life sciences practice, and a managing partner at Vivo Ventures, where he led numerous investments in China. He was also the president of Anesiva, Inc., a biopharmaceutical company focused on pain-management treatments. Earlier in his career, he held senior roles in business development, sales, marketing, and research and development with Tularik Inc. (acquired by Amgen), GlaxoSmithKline LLC, Bristol-Myers Squibb, and ALZA Corp..
James Huang serves as a member of the board of directors of Kindstar Globalgene Technology, Inc., Connect Biopharma Holdings Limited, Lee’s Pharmaceutical Holdings Limited, and several private companies.
James Huang received an M.B.A. from the Stanford Graduate School of Business and a B.S. degree in chemical engineering from the University of California, Berkeley.
About Nachi Subramanian
Nachi Subramanian has served as a Managing Director at the Redmile Group since December 2021. He previously spent fourteen years at J.P. Morgan, where he held senior roles across the Private Markets and Global Cash Equities businesses. He began his career in Institutional Equities at Bear Stearns.
Nachi Subramanian holds a B.A. in Political Science and Economics from the University of California, Irvine.
About Atara Biotherapeutics, Inc.
Atara is a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr Virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases. Atara is headquartered in Southern California.
For more: https://www.atarabio.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.